End stage renal disease is the final stage of chronic kidney disease when the kidneys can no longer work well enough to meet the body’s needs. People with end stage renal disease may feel very tired, short of breath, itchy, or nauseated, and swelling in the legs or face is common. It is a long-term condition that usually follows years of kidney damage, and it affects adults more often but can occur at any age. Treatment focuses on dialysis or a kidney transplant, along with medicines and diet changes to manage features doctors see and symptoms people feel. The outlook varies, but advances in care mean many people with end stage renal disease live longer and more active lives.
Overview
End stage renal diseaseSymptoms
Early symptoms of end stage renal disease can include fatigue, ankle swelling, loss of appetite, and nausea. As it advances, people may have shortness of breath, persistent itching, muscle cramps, trouble sleeping, confusion, and little or no urine.
Outlook and prognosis
Many living with end stage renal disease can do well for years with consistent dialysis, careful fluid and salt management, and support for heart and bone health. Kidney transplant offers the best long-term survival and energy. Outcomes vary by age, other conditions, and treatment access.
Causes and risk factors
End stage renal disease most often follows long-standing kidney damage from diabetes or high blood pressure; other causes include glomerulonephritis, repeated infections, or blockage. Risk factors for end stage renal disease include age, smoking, obesity, certain painkillers, and family history.
Genetic influences
Genetics plays a meaningful role in end stage renal disease, but it’s only part of the picture. Variants in genes like APOL1, PKD1/PKD2, and others can raise risk or speed progression. Family history helps guide screening, while blood pressure, diabetes, and lifestyle still matter greatly.
Diagnosis
Diagnosis of End stage renal disease relies on blood and urine tests showing severely reduced kidney function. Doctors also review symptoms, imaging, and prior chronic kidney disease records to confirm and plan treatment, including dialysis or a transplant.
Treatment and drugs
Treatment for end stage renal disease focuses on replacing kidney function and protecting overall health. Options include hemodialysis or peritoneal dialysis, kidney transplant evaluation, careful fluid and salt management, medicines for blood pressure, anemia, bone health, and infection prevention. Care teams also support nutrition, activity, and emotional well-being.
Symptoms
End stage renal disease can affect energy, appetite, sleep, and how much you urinate. Many symptoms come from waste and fluid building up when the kidneys can no longer keep up. Early symptoms of end stage renal disease may be subtle, like feeling more tired, itchy skin, or swelling in your ankles. Symptoms vary from person to person and can change over time.
Feeling unusually tired, weak, or short on stamina. In end stage renal disease, this often builds gradually and can make everyday tasks feel draining. In medical terms, this is often linked to anemia and toxin buildup; in everyday life, it shows up as low energy.
Puffiness in ankles, feet, legs, hands, or around the eyes from extra fluid. With end stage renal disease, salt and water can accumulate and make rings or shoes feel tight. Clinicians call this edema, which means fluid collecting in tissues.
Breathing can feel harder with activity or when lying flat. End stage renal disease can leave extra fluid in the lungs or reduce oxygen delivery, making you winded.
An upset stomach, queasiness, or throwing up can happen as waste builds up. This often goes along with poor appetite.
How people usually first notice End stage renal disease?
Many people first notice end stage renal disease when earlier chronic kidney disease symptoms intensify: swelling in the legs or around the eyes, extreme fatigue, nausea, loss of appetite, itchiness, and shortness of breath can become hard to ignore. Lab tests often tell the clearer story—very low estimated glomerular filtration rate (eGFR), high creatinine and urea, electrolyte problems like high potassium, and anemia—sometimes found during routine checks for high blood pressure or diabetes before symptoms peak. For families and clinicians, the first signs of end stage renal disease may be frequent nighttime urination turning into very little urine output, rising blood pressure that’s tough to control, and fluid buildup causing rapid weight gain (kilograms or pounds) or trouble breathing.
Types of End stage renal disease
End stage renal disease (ESRD) can look different from one person to the next because the underlying cause, kidney scarring pattern, and treatment approach shape day‑to‑day symptoms. Some types show up more as fluid overload—think swelling in the legs and breathlessness—while others lean toward fatigue, low appetite, and foggy thinking. People may notice different sets of symptoms depending on their situation. When people talk about types of ESRD, they usually mean the main treatment pathways or how kidneys fail over time rather than different diseases altogether; understanding the types of ESRD care can help you anticipate what symptoms may change with each option.
Hemodialysis center-based
Symptoms often improve after sessions, but fatigue or cramps can be stronger on dialysis days. Swelling and breathlessness usually ease as fluid is removed. Some notice dips in blood pressure during treatment.
Home hemodialysis
More frequent or gentler sessions can smooth out symptom swings across the week. People often report steadier energy and less fluid buildup between runs. Training and home setup are required.
Peritoneal dialysis
Daily exchanges can keep fluids and toxins steadier, which may mean fewer ups and downs in how you feel. Bloating or belly fullness can occur from dialysate. Infection risk of the catheter site and abdomen requires careful hygiene.
Conservative management
Focus is on symptom relief without dialysis, emphasizing comfort, nutrition, and fluid balance. Fatigue, itching, nausea, and breathlessness are managed with medicines and lifestyle steps. This approach may suit those with severe other illnesses or personal preference.
Transplant (post-ESRD)
A successful kidney transplant can reverse many day-to-day ESRD symptoms, improving energy, appetite, and mental clarity. Anti-rejection medicines carry their own side effects and infection risks. Not everyone is a candidate right away.
Diabetic kidney failure
Blood sugar and blood pressure control remain central, even on dialysis, to limit cramps, nerve pain, and vision issues. Fluid overload and swelling may be more pronounced. Heart risks tend to be higher.
Hypertensive kidney failure
Long-standing high blood pressure can lead to headaches, breathlessness, and heart strain. Strict pressure control helps reduce dizziness on dialysis and protect blood vessels. Salt and fluid limits are key.
Polycystic kidney disease
Enlarged kidneys can cause back or side pain and early fullness when eating. People may have cyst-related infections or blood in the urine before ESRD. Family screening and blood pressure control are often part of care.
Glomerular disease-related
When the kidney filters scar, swelling around the eyes, foamy urine, and high cholesterol may precede ESRD. On dialysis, fluid shifts can still drive puffiness and blood pressure changes. Immunosuppression history may shape infection risk.
Vascular access differences
A fistula often allows good blood flow with fewer infections, while a catheter can mean more infections and clot risk. Symptoms related to access include arm swelling, hand numbness, or line site discomfort. Choosing and caring for access can change the pattern of symptoms.
Anemia-dominant pattern
Low red blood cells can drive deep tiredness, pale skin, and shortness of breath. Treatment with iron and erythropoietin can lift energy and focus. Even within the same type, intensity can range from mild to severe.
Mineral-bone disorder
Itching, bone pain, and muscle cramps may stand out when calcium and phosphorus are off. Phosphate binders, vitamin D, and dialysis adjustments help steady these symptoms. Parathyroid hormone levels guide treatment.
Fluid-overload predominant
Leg swelling, sudden weight gain, and nighttime breathlessness are common. Dialysis ultrafiltration, salt restriction, and diuretics (if some kidney function remains) reduce these symptoms. Loved ones may recognize certain types sooner than the person experiencing them.
Uremic symptoms predominant
Nausea, metallic taste, poor appetite, and mental fog can lead. Dialysis intensity and timing often target these, and transplant can resolve many. Keeping track of which type you experience most can help tailor care.
Infection-prone course
Repeated access or peritoneal infections can cause fever, fatigue, and treatment interruptions. Swift antibiotics and revisiting access type may reduce future episodes. Share with your healthcare provider whether symptoms cluster after treatments.
Cardiovascular-heavy burden
Chest pressure, irregular heartbeat, and exercise limits can dominate. Care focuses on fluid control, blood pressure, and heart-protective medicines. If a new type appears, it’s worth checking in with your care team to adjust the plan.
Malnutrition-inflammation
Unintended weight loss, weak grip strength, and low albumin may be more noticeable than swelling. Dietitian support, anti-inflammatory care, and optimized dialysis can help. Daily life often makes the differences between symptom types clearer.
Older adult focus
Dizziness, falls, and medication side effects may take priority over swelling or cramps. Gentle dialysis prescriptions and simpler regimens can improve comfort. Not everyone will experience every type.
Younger adult focus
Work, school, and fertility planning shape symptom priorities alongside cramps or fatigue. Home therapies or transplant planning may reduce missed days and improve quality of life. When people talk about types of ESRD, they often mean how treatment choices change daily symptoms.
Early ESRD transition
As kidney function drops to single digits (eGFR about 5–10 mL/min/1.73 m²), nausea, itching, and sleep problems may rise. Early symptoms of ESRD can improve once a stable dialysis or transplant plan is in place. Clinicians often describe them in these categories:
What genetics can tell you about symptoms
Certain inherited changes, like APOL1 risk variants in people of African ancestry, can speed kidney scarring and raise the chance of earlier dialysis or transplant. Variants causing polycystic kidney disease (PKD1/PKD2) lead to growing kidney cysts, high blood pressure, pain, and faster kidney failure.
Causes and risk factors
Long-term diabetes and high blood pressure are the leading causes. Family history can be one part of the story, but lifestyle and environment add their own chapters. Other causes include kidney filter inflammation and scarring from infections or autoimmune disease. Polycystic kidney disease and long-term blockage of urine flow can also lead to kidney failure. Risk factors for End stage renal disease include older age and obesity, long-term use of some anti-inflammatory painkillers, and APOL1 gene changes in some people of African ancestry.
Environmental and biological risk factors
End stage renal disease (ESRD) develops after long-term kidney damage gradually reduces function. Understanding which body-based and environmental exposures raise risk can help you protect remaining kidney function. Doctors often group risks into internal (biological) and external (environmental).
High blood sugar damages the tiny filters in the kidneys over time. Long-standing or poorly controlled diabetes raises the chance of end stage renal disease.
Constant high pressure strains kidney blood vessels and causes scarring. When blood pressure stays high for years, the risk of end stage renal disease increases.
Conditions where the immune system attacks the kidney filters can scar them. Repeated bouts of inflammation make long-term loss of function and end stage renal disease more likely.
Protein leaking into urine is a sign that filters are damaged. Higher or persistent protein levels predict faster kidney decline and a greater chance of end stage renal disease.
Genetic risk factors
If kidney failure runs in a family, it often raises questions about inherited risk. Several well-established genetic conditions and variants can directly affect the kidney’s filters or structure and increase the chance of end stage renal disease. Carrying a genetic change doesn’t guarantee the condition will appear, but it can change the timeline or severity. Understanding the genetic causes of end stage renal disease can guide testing for relatives and planning for monitoring.
APOL1 variants: Certain APOL1 gene changes, most common in people with West or sub-Saharan African ancestry, can raise lifetime risk for kidney scarring and end stage renal disease. Risk is highest when two high-risk variants are inherited. Many with these variants never develop kidney failure.
Polycystic kidney disease: Autosomal dominant polycystic kidney disease causes many fluid-filled cysts that enlarge kidneys over decades. A single altered PKD1 or PKD2 gene from either parent can be enough. Many people reach kidney failure in mid-to-late adulthood, though timing varies by family.
Alport syndrome: Changes in COL4A3, COL4A4, or COL4A5 affect the collagen that supports the kidney filter. X-linked forms often cause faster decline in males, with females showing slower progression. Hearing or eye findings can occur in some families.
UMOD/MUC1 variants: Pathogenic changes in UMOD or MUC1 cause autosomal dominant tubulointerstitial kidney disease. Kidney function usually falls slowly from adolescence or adulthood, with end stage renal disease developing in midlife for many. Age of onset can differ widely within the same family.
Nephrotic syndrome genes: Variants in genes such as NPHS1, NPHS2, or WT1 can cause steroid-resistant nephrotic syndrome. Heavy protein loss injures kidney filters and may lead to kidney failure in childhood or young adulthood. Genetic confirmation can clarify prognosis.
HNF1B changes: HNF1B gene changes can lead to kidney cysts and other developmental differences, sometimes alongside diabetes. Kidney function decline ranges from mild to severe, even within one family. Some individuals reach kidney failure in early to mid-adulthood.
Complement pathway genes: Changes in complement genes such as CFH, CFI, C3, CFB, or MCP can predispose to atypical hemolytic uremic syndrome or C3 glomerulopathy. These conditions can damage kidney filters and progress to end stage renal disease. Inheritance can be dominant or recessive depending on the gene.
CAKUT genes: Variants in genes involved in kidney development, including PAX2, EYA1, or HNF1B, can cause congenital anomalies of the kidneys and urinary tract. Severity ranges from mild size differences to absent or poorly formed kidneys. When both kidneys are affected, risk of kidney failure increases.
Sickle cell disease: Inherited hemoglobin S can injure small blood vessels in the kidney over time. People with sickle cell disease have higher risk of chronic kidney disease and eventual kidney failure. Severity varies by genotype and genetic modifiers.
Polygenic background: Many common DNA changes each add a small amount of kidney risk. Together with family history, this polygenic background can raise the chance of end stage renal disease. Effects differ across ancestries and are being mapped in ongoing research.
Lifestyle risk factors
Daily habits can strongly influence the chances of reaching end stage renal disease and the speed at which kidney function declines. The lifestyle risk factors for end stage renal disease center on blood pressure, blood sugar, weight, inflammation, and direct kidney toxins. Small, sustained changes in eating patterns, movement, and substance use can meaningfully slow kidney damage.
Excess salt raises blood pressure and protein loss in urine, accelerating kidney scarring. Reducing sodium lowers filtration pressure and can slow chronic kidney disease toward ESRD.
Regular intake drives weight gain and insulin resistance that worsen diabetic kidney injury. Swapping to water or unsweetened drinks supports glucose control and protects remaining kidney function.
Very high animal-protein diets increase glomerular hyperfiltration and acid load, hastening decline. Moderating protein and emphasizing plant sources can reduce kidney stress.
Phosphate additives and hidden salt disrupt mineral balance and stiffen blood vessels, speeding loss of kidney function. Cooking more fresh foods lowers additive phosphate and sodium exposure.
Risk prevention
End stage renal disease (ESRD) usually develops after years of kidney strain from conditions like diabetes or high blood pressure. The goal is to slow kidney damage early and protect the blood vessels that feed the kidneys. Prevention works best when combined with regular check-ups. The steps below focus on controlling risks, catching problems early, and avoiding hits to the kidneys.
Keep blood pressure near your target, often around 120–130/70–80 mmHg as advised by your doctor. Home monitoring and taking prescribed medicines consistently protect kidney filters.
If you live with diabetes, aim for a safe A1C target you and your clinician set together. Steady glucose lowers kidney stress and slows scarring.
Ask whether an ACE inhibitor, ARB, or an SGLT2 inhibitor is right for you. These medicines can reduce urine protein and help delay kidney function loss.
Choose meals with less than 2,000 mg sodium per day (about 5 g salt, roughly 1 teaspoon). Lower salt helps control blood pressure and fluid build-up.
Transmission
End stage renal disease is not contagious and cannot be passed from one person to another. You can’t “catch” it through everyday contact, kissing, sex, coughing, sharing dishes, or using the same dialysis room; receiving a kidney transplant does not transmit end stage renal disease, and donated kidneys are carefully screened. End stage renal disease develops over time from ongoing kidney damage—most often from diabetes or high blood pressure—and while the condition itself is not inherited, risk can run in families because some causes of kidney failure can be passed down. If you’re wondering about how end stage renal disease is inherited, the key point is that certain kidney diseases may be inherited, but end stage renal disease itself is not. This condition does not spread in homes, communities, or healthcare settings.
When to test your genes
Consider genetic testing if kidney failure appeared at a young age, runs in your family, or came with hearing or eye issues, cysts, or blood in urine. Test if you’re planning a transplant or choosing dialysis, since certain gene findings guide donor matching, medications, and surveillance. Ask earlier if you’re from a high‑risk ancestry or had unexplained kidney scarring.
Diagnosis
When kidneys are failing, everyday tasks—walking up stairs, concentrating at work, keeping up with family—can start feeling harder. Swelling in the legs, nausea, or very low energy may be what finally brings someone in for testing. Doctors usually begin with a careful review of symptoms, blood and urine tests, and a physical exam. Understanding how end stage renal disease is diagnosed can help you know what to expect.
Your clinician reviews symptoms like fatigue, swelling, shortness of breath, and changes in urination. They check blood pressure, weight, and look for fluid buildup in the legs or around the eyes.
A blood creatinine test is used to estimate glomerular filtration rate (eGFR). An eGFR consistently below 15 mL/min/1.73 m² signals end stage renal disease.
Panels check creatinine, urea (BUN), electrolytes, and acid–base balance. These results show how well the kidneys are filtering and help confirm severity.
A urine dipstick and lab analysis look for protein, blood, and other markers of damage. Low or minimal urine output may point to advanced kidney failure.
Stages of End stage renal disease
End stage renal disease does not have defined progression stages. It is the final (stage 5) phase of chronic kidney disease, so care focuses on dialysis or transplant and on preventing and treating complications; many people feel relief once they understand what’s happening. Doctors confirm and monitor end stage renal disease with blood and urine tests, estimated filtration rate, blood pressure checks, and by tracking symptoms and fluid balance, and they also plan for dialysis access or transplant evaluation. Because early symptoms of end stage renal disease can be subtle or overlap with advanced kidney disease—like tiredness, swelling, itch, or changes in urination—regular follow-up helps catch changes early.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, and for end stage renal disease the answer depends on the treatment path you choose and your overall health. Dialysis can keep you alive for many years by doing the work of your kidneys—filtering waste and extra fluid—but it also brings daily limits like strict fluid control, frequent clinic visits, and higher risks of infections, heart problems, and hospital stays. Kidney transplant, when possible, typically offers the best survival and quality of life, with more energy, fewer diet limits, and better heart protection than long-term dialysis. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, along with age, diabetes, blood pressure control, and how early symptoms of end stage renal disease are recognized and treated.
Here’s what research and experience suggest about the future. On average, people on dialysis live several years, though many live longer with good blood pressure, anemia, and mineral balance management; the main causes of death are heart disease and infections. After a successful kidney transplant, many people maintain decades of added life, though you’ll need lifelong immune-suppressing medicines and regular follow-up to protect the new kidney. Everyone’s journey looks a little different.
Early care can make a real difference, including getting on the transplant list promptly, choosing a dialysis type that fits your life, staying up to date on vaccines, and keeping diabetes and blood pressure tightly managed. Support from friends and family can help with daily routines, from rides to dialysis to keeping track of medicines and appointments. Talk with your doctor about what your personal outlook might look like, including whether transplant evaluation, home dialysis options, or clinical trials could improve both length and quality of life.
Long-term effects
Living with end stage renal disease can affect energy, thinking, and how easily you keep up with daily plans over the years. Outlook depends on your age, other health conditions, and whether you’re on dialysis or had a kidney transplant. Long-term effects vary widely, and they don’t look the same for everyone. Some changes slowly build, while others show up during hospital stays or after infections.
The long-term risk of heart disease and stroke is higher. Blood pressure and blood vessel stiffness can worsen with time.
Mineral imbalances can weaken bones and joints. This raises the chance of bone pain and fractures, and calcium can harden vessels or soft tissues.
Fewer red blood cells can leave you tired, short of breath, or lightheaded. This low-blood count pattern often persists without targeted treatment.
Tingling, numbness, or burning pain in the feet and hands can develop. Some notice muscle weakness or restless legs over time.
How is it to live with End stage renal disease?
Living with end stage renal disease often means building your days around treatment, energy levels, and careful planning. Many people balance dialysis sessions or post-transplant care with work, family, and the routines that keep them feeling steady, while managing symptoms like fatigue, itching, sleep changes, or muscle cramps. Meals, fluids, and medicines require attention, but support from clinicians, loved ones, and peer communities can lighten the load and make room for the parts of life that matter. Those around you may take on more practical tasks and emotional support, and open communication helps everyone adapt together.
Treatment and drugs
End stage renal disease is treated with therapies that replace or support lost kidney function and address symptoms day to day. Most people choose between dialysis and a kidney transplant; dialysis can be done at a center or at home, either with hemodialysis (using a machine to filter blood) or peritoneal dialysis (using the lining of your abdomen), while transplant offers the best long-term quality of life for many who are eligible. Medicines that ease symptoms are called supportive or adjunct therapies, and may include treatments to manage blood pressure, anemia, bone and mineral balance, swelling, itching, and acid levels, plus vaccines and antibiotics to prevent or treat infections. Alongside medical treatment, lifestyle choices play a role, such as limiting salt and fluid, following a kidney-friendly eating plan with a dietitian, staying up to date with vaccinations, and keeping active as you’re able. Not every treatment works the same way for every person, so your care team will tailor a plan—dialysis type, transplant timing, and medications—to your goals, other health conditions, and what fits your routine.
Non-drug treatment
For people living with end stage renal disease, care beyond prescriptions focuses on dialysis choices, nutrition, and day-to-day support. Alongside medicines, non-drug therapies can ease symptoms and support daily life. Education also helps you spot early symptoms of end stage renal disease complications, like fluid overload or infection, so you can act promptly. Plans are tailored to your dialysis type, other health conditions, and personal goals.
Learn the differences between in-center hemodialysis, home hemodialysis, and peritoneal dialysis. Understanding schedules, equipment, and lifestyle fit helps you choose what works best. This can make living with end stage renal disease feel more manageable.
Hands-on teaching shows you how to set up, run, and clean equipment safely. You’ll practice infection prevention and troubleshooting. This builds confidence if you choose home treatment for end stage renal disease.
Daily skin checks, gentle washing, and protecting your access help prevent infections and clots. Nurses teach safe needle-site rotation and warning signs that need prompt care. Good routines can keep treatments running smoothly.
A kidney dietitian helps tailor protein, salt, potassium, and phosphorus goals. Meal planning can reduce swelling, protect the heart, and improve energy. Nutrition guidance often eases symptoms of end stage renal disease.
Your genes may have an impact on how drugs work for you
Two people with end stage renal disease can take the same drug yet respond differently because gene differences affect how the body activates, breaks down, or transports medicines. Pharmacogenetic testing can sometimes guide safer doses or better choices, alongside kidney function–based adjustments.
Pharmacological treatments
Medicines for end stage renal disease (ESRD) are used to support dialysis, manage anemia, protect bones, control blood pressure and potassium, and ease symptoms like itching and nausea. Some medicines can also relieve early symptoms of end stage renal disease, such as loss of appetite or restless itching. Alongside drug therapy, dialysis and nutrition remain important. Your team will tailor choices to your lab results, remaining kidney function, and day-to-day needs.
Epoetin alfa and darbepoetin alfa stimulate red blood cell production to treat anemia in end stage renal disease. They are given as injections and require regular blood tests to target a safe hemoglobin range.
Iron sucrose, ferric gluconate, or ferric carboxymaltose replace iron stores so anemia medicines can work properly. These are usually given during dialysis with monitoring for reactions and iron levels.
Sevelamer, calcium acetate, lanthanum carbonate, or sucroferric oxyhydroxide trap phosphate from food in the gut. This helps protect bones and blood vessels in people with end stage renal disease. Calcium-based binders may raise calcium levels, so labs guide the choice.
Calcitriol or paricalcitol help balance calcium and parathyroid hormone to support bone health. Doses are adjusted using blood tests to lower overactive parathyroid hormone without causing high calcium or phosphate.
Genetic influences
Genetics can shape how likely someone is to develop severe kidney damage over time, and in some families that risk is higher due to inherited kidney conditions. Disorders such as polycystic kidney disease, Alport syndrome, and some rare problems with the kidney’s filters or tubules can gradually scar the kidneys and eventually lead to end stage renal disease (ESRD). Certain gene changes, including APOL1 variants that are more common in people with African ancestry, can also raise the chance of kidney failure when combined with other health stresses like high blood pressure or infections. Having a genetic risk is not the same as having the disease itself. Most cases involve a mix of factors—genes interacting with conditions like diabetes and hypertension, plus life-course influences—so relatives may have very different outcomes even with similar backgrounds. If kidney problems cluster in your family, genetic testing for end stage renal disease risk and a careful review of family history can help clarify the cause, guide treatment, and inform screening for relatives.
Is End stage renal disease genetic?
Genetics plays a meaningful role in end stage renal disease, but it’s only part of the picture. Variants in genes like APOL1, PKD1/PKD2, and others can raise risk or speed progression. Family history helps guide screening, while blood pressure, diabetes, and lifestyle still matter greatly.
Pharmacogenetics—how genetics influence drug effects
In end stage renal disease, many medicines are part of daily life—from blood pressure pills and phosphate binders to pain relievers and, after transplant, anti-rejection drugs. Small inherited differences can change how your body absorbs, breaks down, or responds to these medicines, which may affect which drug works best or what dose is safest. For example, differences in drug‑processing enzymes can change how strongly codeine or tramadol relieve pain, and some people need different options to avoid side effects. After a kidney transplant, genetics can also influence the dose of tacrolimus (a common anti‑rejection medicine), with some people needing higher or lower amounts to reach the right level. Similar patterns apply to certain heart and blood‑thinner medicines often used in end stage renal disease, where genetics may guide dosing or choice. Genetics is only one factor—dialysis, reduced kidney clearance, other medicines, and diet also shape drug response—so pharmacogenetic testing in end stage renal disease is usually used alongside your medical history and careful monitoring.
Interactions with other conditions
Day-to-day, people with End stage renal disease often manage other conditions that affect how they feel and how treatment goes. Doctors call it a “comorbidity” when two conditions occur together. Diabetes and high blood pressure commonly travel with End stage renal disease; blood sugar may be harder to control on dialysis days, and blood pressure can swing with fluid shifts, so medicines sometimes need careful timing or dose changes. The risk of heart disease in end stage renal disease is high, and heart failure or irregular heartbeats can worsen with extra fluid or rapid fluid removal, while heart problems can make dialysis sessions more challenging.
Infections may be more frequent because the immune system is strained and vascular access is needed, and anemia or bone and mineral problems can compound fatigue and muscle aches. Nerve pain, sleep apnea, depression, and malnutrition can also interact with End stage renal disease, making recovery from illness slower and daily energy lower. Interactions can look very different from person to person, so coordinated care between kidney, heart, diabetes, and primary care teams helps tailor a plan that fits your health and your routine.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described swelling, fatigue, and a “watery” look that we now recognize as signs of failing kidneys. Families noticed loved ones who stopped making much urine, felt nauseated, and grew weak despite eating. In some communities, people with long‑standing “dropsy” or high blood pressure often developed these problems late in life; without effective treatments, many became too tired to work or walk far.
First described in the medical literature as “Bright’s disease” in the 1800s, kidney failure was initially understood through what doctors could see and feel—swollen legs, changes in urine, shortness of breath. Microscopes and early chemistry then showed waste products building up in the blood. Over time, descriptions became more precise: scarring from long‑term high blood pressure, damage from diabetes, inherited conditions like polycystic kidneys, and repeated infections all led down similar pathways to what we now call end stage renal disease.
As medical science evolved, surgeons attempted kidney transplants in the early 1900s, but the body’s rejection made success rare. The 1940s brought the first workable dialysis machines, and by the 1960s, hemodialysis units and home peritoneal dialysis began saving lives. These advances turned end stage renal disease from a sudden terminal phase into a chronic condition that could be managed, allowing many people to work, travel, and raise families while on dialysis or after transplant.
In recent decades, awareness has grown about the major drivers of end stage renal disease—especially diabetes and high blood pressure—and about disparities in who is affected. Blood and urine tests made it possible to catch early symptoms of end stage renal disease, often before someone felt unwell. Better blood pressure medicines, diabetes care, and protective drugs such as ACE inhibitors slowed the slide toward kidney failure for many.
Building on this early work, scientists mapped how scarring progresses inside the kidney’s filters and how immune responses and toxins from uremia affect the whole body. Safer surgery, improved tissue matching, and modern anti‑rejection drugs transformed kidney transplantation into the preferred long‑term therapy for many. Today, ongoing research focuses on preventing progression, tailoring dialysis to reduce strain on the heart, and widening access to transplant.
Looking back helps explain why end stage renal disease is approached as both a kidney problem and a whole‑body condition. The history shows steady shifts—from bedside observations to lab measurements, from heroic early machines to routine dialysis, and from experimental grafts to standard transplants. Each step has shaped current care, with the goal of helping people with end stage renal disease live longer, fuller lives.